Actively Recruiting
High Resolution, High-speed Multimodal Ophthalmic Imaging
Led by Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts · Updated on 2025-11-18
1200
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Knowledge of the pathogenesis of ocular conditions, a leading cause of blindness, has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems are limited in resolution, speed, or access to certain structures of the eye. The use of a high-resolution imaging system improves the resolution of ophthalmoscopes by several orders of magnitude, allowing the visualization of many microstructures of the eye: photoreceptors, vessels, nerve bundles in the retina, cells and nerves in the cornea. The use of a high-speed acquisition imaging system makes it possible to detect functional measurements such as the speed of blood flow. The combination of data from multiple imaging systems to obtain multimodal information is of great importance for improving the understanding of structural changes in the eye during a disease. The purpose of this project is to observe structures that are not detectable with routinely used systems.
CONDITIONS
Official Title
High Resolution, High-speed Multimodal Ophthalmic Imaging
Who Can Participate
Eligibility Criteria
You may qualify if you...
- People over 18
- Patients with an eye pathology or healthy volunteers
- Participants who have signed consent
- Beneficiaries of health insurance
You will not qualify if you...
- History of photosensitivity
- Recent photodynamic therapy treatment
- Use of drugs causing photosensitivity as a side effect
- Presence of pacemaker or implanted electronic medical device
- Viral conjunctivitis or other infectious eye disease
- Skin lesions on neck or forehead
- High risk of damage from optical radiation (e.g., aphakic patients or decreased light sensitivity due to fundus disease)
- Pregnant or lactating women
- Inability to be followed throughout the study
- Vulnerable individuals
- Predisposition to closure of the iridocorneal angle
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Paris, France, 75012
Actively Recruiting
Research Team
N
Nabil BROUK
CONTACT
A
Azedine DJABALI
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here